Opportunities
Search

Buyer: Freistaat Bayern Vertreten durch die Akademie für Lehrerfortbildung und Personalführung (ALP) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Woonsprong bv | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: Regione Autonoma della Sardegna | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Rijkswaterstaat Programma's, Projecten en Onderhoud | Notice type: cn-standard | Procedure: comp-dial | Contract: works | Deadline: 2026-09-24

Buyer: SBB CFF FFS Einkauf Bauprojekte Standort Bern | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: Zweckverband ARA Untermarch | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Contractables | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: SBB CFF FFS Einkauf Bauprojekte Standort Bern | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: SBB CFF FFS Einkauf Bauprojekte Standort Bern | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: APRR. | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: Bundesministerium für Inneres | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-24

Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-24

Buyer: Thüringer Landesamt für Bau und Verkehr | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Consejo de Administración de la Empresa de Servicios Municipales de Alcorcón, S.A.U. | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2026-09-24

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis.Distinctive Features:Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required.Community collaboration is required for studies prospectively enrolling human subjects.Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD).Distinctive Features:• Applications must address at least one of the following focus areas: ○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here. ○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD.• Clinical research is allowed, however clinical trials and animal research are prohibited.• Preliminary data are required.• Community collaboration is required for research prospectively enrolling human subjects.• Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s).Distinctive Features:Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity.Studies utilizing animal models do not meet the intent of the mechanism and are not allowed.Preliminary data are required.Community collaboration is required for research prospectively enrolling human subjects.The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Buyer: Forchbahn AG (Bund) | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-25

Buyer: CENTRE HOSPITALIER DE SAINT-DENIS | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-25

Buyer: Gemeente Den Haag | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-25

Buyer: CH UNIVERSITAIRE D ORLEANS | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-25

Buyer: Communauté d'Agglomération de Dembéni-Mamoudzou (976) | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-25

Buyer: 95 CH | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-25

Buyer: VILLE D'EMBRUN | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-25